Jacqualyn A. Fouse
2012 - Celgene
In 2012, Jacqualyn A. Fouse earned a total compensation of $3.5M as President Hematology and Oncology at Celgene, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $505,951 |
|---|---|
| Option Awards | $1,178,617 |
| Salary | $729,167 |
| Stock Awards | $1,018,083 |
| Other | $18,285 |
| Total | $3,450,103 |
Fouse received $1.2M in option awards, accounting for 34% of the total pay in 2012.
Fouse also received $506K in non-equity incentive plan, $729.2K in salary, $1M in stock awards and $18.3K in other compensation.
Rankings
In 2012, Jacqualyn A. Fouse's compensation ranked 1,967th out of 11,487 executives tracked by ExecPay. In other words, Fouse earned more than 82.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,967 out of 11,487 | 83rd |
Division Manufacturing | 696 out of 4,253 | 84th |
Major group Chemicals And Allied Products | 157 out of 1,203 | 87th |
Industry group Drugs | 89 out of 925 | 90th |
Industry Pharmaceutical Preparations | 74 out of 700 | 89th |
Source: SEC filing on April 30, 2015.
Fouse's colleagues
We found four more compensation records of executives who worked with Jacqualyn A. Fouse at Celgene in 2012.